Article
Targeting FGFR in bladder cancer: ready for clinical practice?
Acta clinica Belgica - 1 Feb 2020
De Keukeleire Stijn, De Maeseneer Daan, Jacobs Celine, Rottey Sylvie
Abstract excerpt
Objective: To give a brief literature overview of current knowledge regarding FGFR inhibition in bladder cancer.Background: The deeper molecular understanding of bladder urothelial carcinoma (UC) has reshaped the diagnostic and therapeutic landscape of this malignancy. Rapid technological development, including the frequent use of next-generation sequencing (NGS) in clinical practice, has boosted identification...
Topics
Join the communities discussing this publication.